Tooluck, it's a good question. Why dont they gobble us up? More...

Tooluck, it's a good question. Why dont they gobble us up?

More broadly we're mostly in drugs that are mostly treating short term, mostly self limiting problems. Big Pharma prefer drugs that are taken for prolonged periods, preferably for the rest of the patients' lives.

More specifically we're in a poor royalty arrangement with GSK for Relenza and in partnership with DS for LANI. Our other programs, while very exciting are still too early stage... except for Vapen, for which we only got proof of concept a month ago.

I think we have good science, virtually all our programs have had competitive based funding support from various govt agencies....

As for a US CEO I would dearly love an ex Gilead executive to take over the reigns.